A German company claims to have found the key to the fight against cancer

SEEN FROM ELSEWHERE – A German company from Cologne has found a promising approach. Its researchers have just received new funds injected by a renowned and controversial investor.

By Anja Ettel and Holger Zschäpitz (Die Welt)

Investor Frank Thelen once had many dreams – driving flying cars or being able to eat without having to cook. Freigeist (“free spirit”), his Bonn-based investment company, wants to use his funds to make these dreams a reality. Such is at least his ambition, even if the reality is often different – like the results of his fund open to the public 10xDNA Disruptive Technologies, which he launched with great fanfare last year and which was to allow small savers to benefit from the profits of exponentially growing companies.

This article is for subscribers only. You have 93% left to discover.

Pushing back the limits of science is also freedom.

Keep reading your article for €0.99 for the first month

Already subscribed? Login


Leave a Reply

Your email address will not be published. Required fields are marked *